NCT06558487

Brief Summary

The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with an active cancer diagnosis visiting the emergency department (ED). The main question it aims to answer are: Is the performance of the CAS good enough to play a potential role in the ED care process. For each participant the CAS will be calculated and compared to the actual outcome.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 16, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

December 2, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 15, 2025

Status Verified

August 1, 2025

Enrollment Period

12 months

First QC Date

August 14, 2024

Last Update Submit

August 12, 2025

Conditions

Keywords

cancer careemergency careprediction modeladmission

Outcome Measures

Primary Outcomes (3)

  • Cancer Admission Score

    Cancer Admission Score (CAS) calculated after triage and after first blood results, ranging from 0 to 100%. The higher the score the greater the change of admission

    Through study completion, an average of 6 months

  • Disposition

    The outcome of a visit to the ED, being either admission or home

    Through study completion, an average of 6 months

  • Agreement between the CAS and the actual disposition

    Agreement between the CAS predicted outcome and the actual outcome

    Through study completion, an average of 6 months

Secondary Outcomes (4)

  • Agreement between expected disposition by nurse and actual disposition

    Through study completion, an average of 6 months

  • time-to-disposition

    Through study completion, an average of 6 months

  • time-to-leave

    Through study completion, an average of 6 months

  • ED Length of Stay

    Through study completion, an average of 6 months

Other Outcomes (7)

  • Sex

    Through study completion, an average of 6 months

  • Age

    Through study completion, an average of 6 months

  • Type of Cancer

    Through study completion, an average of 6 months

  • +4 more other outcomes

Study Arms (1)

Cancer patients

All adult patients with an active cancer diagnosis who visit the emergency department (ED) of the Erasmus University Medical Centre (Erasmus MC).

Other: Cancer Admission Score Prediction Model

Interventions

A prediction model that calculates the chance for a patient to be admitted after triage and after first blood results

Cancer patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult patients with an active cancer diagnosis who visit the ED of the Erasmus University Medical Center (Erasmus MC).

You may qualify if:

  • Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months.
  • Presented at or admitted from the emergency department for the oncology, hematology neuro- or lung-oncology clinical unit.

You may not qualify if:

  • \<18 years old
  • Only received a surgical intervention as cancer treatment
  • Admitted to the ED for the surgical department

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasmus University Medical Center

Rotterdam, South Holland, 3015GD, Netherlands

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Jason den Duijn

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jason den Duijn

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 14, 2024

First Posted

August 16, 2024

Study Start

December 2, 2024

Primary Completion

December 1, 2025

Study Completion

December 31, 2025

Last Updated

August 15, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations